Rossari Biotech Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 28-06-2024
- Paid Up Capital ₹ 11.05 Cr
as on 28-06-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 278.12 Cr
as on 28-06-2024
- Satisfied Charges ₹ 65.54 Cr
as on 28-06-2024
- Revenue -9.84%
(FY 2023)
- Profit -10.17%
(FY 2023)
- Ebitda -0.12%
(FY 2023)
- Net Worth 9.45%
(FY 2023)
- Total Assets 21.57%
(FY 2023)
About Rossari Biotech
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543213 and on the National Stock Exchange(NSE) under ROSSARI.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 11.05 Cr.
The company currently has active open charges totaling ₹278.12 Cr. The company has closed loans amounting to ₹65.54 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Rossari Biotech Limited India are Ketan Sablok as CFO and Parul Gupta as Company Secretary. Sunil Chari, Edward Menezes, Aseem Dhru, and Three other members serve as directors at the Company.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rossari Biotech Limited offer?
Rossari Biotech Limited offers a wide range of products and services, including Paint Finishes, Speciality Chemicals, Thread Lubricant, Sewing Thread Lubricants, Textile, Dyeing & Finishing Chemical.
Who are the key members and board of directors at Rossari Biotech?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Chari  | Managing Director | 10-Aug-2009 | Current |
| Ketan Sablok | CFO | 01-May-2023 | Current |
| Parul Gupta | Company Secretary | 18-Nov-2019 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sharabh Pachory | Director | 12-Nov-2019 | Current |
| Edward Menezes | Director | 10-Aug-2009 | Current |
| Aparna Sharma | Director | 29-Apr-2023 | Current |
| Aseem Dhru | Director | 12-Nov-2019 | Current |
| Esha Achan | Director | Current |
Financial Performance and Corporate Structure Insights of Rossari Biotech.
Rossari Biotech Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.84% decrease. The company also saw a substantial fall in profitability, with a 10.17% decrease in profit. The company's net worth moved up by a moderate rise of 9.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rossari Biotech?
In 2023, Rossari Biotech had a promoter holding of 58.40% and a public holding of 41.60%. The company had 5 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Romakk Chemicals Private LimitedActive 3 years 9 monthsSunil Chari, Edward Menezes and 2 more are mutual person
Buzil Rossari Private LimitedActive 10 years 11 monthsSunil Chari and Edward Menezes are mutual person
Unitop Chemicals Private LimitedActive 44 years 4 monthsSunil Chari, Edward Menezes and 1 more are mutual person
Tristar Intermediates Private LimitedActive 27 years 3 monthsSunil Chari and Edward Menezes are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 23 Feb 2023 | ₹25.00 Cr | Open |
Citi Bank N.A. Creation Date: 12 Oct 2022 | ₹45.00 Cr | Open |
Citi Bank N.A. Creation Date: 12 Oct 2022 | ₹50.00 Cr | Open |
How Many Employees Work at Rossari Biotech?
Rossari Biotech has a workforce of 459 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rossari Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rossari Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
